Diabetic Ketoacidosis (DKA) Diagnosis, Treatment & Cost

✅Diabetic Ketoacidosis Tests

To confirm hyperglycemia, ketosis, and metabolic acidosis in diabetic ketoacidosis, emergency physicians perform diagnostic tests. To identify DKA, the following tests may be recommended:

• Laboratory investigations
• Additional tests
  
  

Laboratory investigations

Laboratory tests are important for confirming the diagnosis of Diabetic Ketoacidosis (DKA), determining its severity, and identifying underlying causes.

The following laboratory tests are commonly performed in the evaluation of diabetic ketoacidosis:

• Serum glucose
• Venous blood gas
• Anion gap
• Serum or capillary β-hydroxybutyrate (preferred over urine ketones)
• Serum electrolytes
• Serum BUN/creatinine
• Serum sodium calculation
• Complete blood picture (CBC)
• Urinalysis
  
  

Serum glucose: A key laboratory test for diabetic ketoacidosis is serum glucose levels, which are usually higher than 250 mg/dL. This is part of the criteria for diagnosing DKA and shows that the body is not producing enough insulin and cannot use it properly. This number helps differentiate DKA from other metabolic emergencies, but it could be lower in cases of euglycemic DKA (glucose level normal or mildly elevated). All other criteria, such as acidosis and ketones, must also be present for a diagnosis.

Venous blood gas: In diabetic ketoacidosis, venous blood gas (VBG) usually shows metabolic acidosis with a pH < 7.30 and a serum bicarbonate < 15-18 mEq/L, indicating the severity of acidemia.

Anion gap: The most common way to find the anion gap is to use Na⁺ + K⁺ – (Cl⁻ + HCO₃⁻), but some studies also use a standard of Na⁺ – (Cl⁻ + HCO₃⁻). The normal range is usually 4–12 mmol/L (or 8–12). A high anion gap (>12 mmol/L) does mean that metabolic acidosis is present, which is a sign of diabetic ketoacidosis.

Serum or capillary β-hydroxybutyrate (preferred over urine ketones): Serum or capillary β-hydroxybutyrate (β-OHB) is the main ketone body that rises in diabetic ketoacidosis (DKA). It is a better lab test than urine ketones. Along with hyperglycemia and acidosis, it uses 3.0 mmol/L for all, regardless of age. Point-of-care testing of capillary β-OHB shows a very good match with serum levels, helping monitor ketonemia and assess treatment response in children with DKA.

Serum electrolytes: Key reflecting electrolyte imbalance in diabetic ketoacidosis include often low serum sodium (hyponatremia) and variable serum potassium (may be high initially, but total body potassium is depleted due to extracellular shift from acidosis and insulin deficiency) upon diagnosis and monitoring.

Serum BUN/creatinine: As part of the DKA assessment, renal function tests like serum blood urea nitrogen (BUN) and creatinine are regularly done to look for dehydration and acute kidney injury. However, the guideline does not give specific numeric cut-offs. In clinical practice, patients with DKA usually have elevated BUN (about 16–22 mg/dL) and creatinine (about 0.8–1.3 mg/dL) because of dehydration and have prerenal azotemia (elevated blood levels of urea and creatinine), indicating that the kidneys are not receiving sufficient blood flow during a hyperglycemic crisis.

Serum sodium calculation: In diabetic ketoacidosis (DKA), the serum sodium level is often falsely low due to the osmotic effect of elevated glucose (high glucose levels pull water into the blood, which lowers sodium levels and makes them look lower (translocational hyponatremia). To get an accurate picture of sodium status and guide fluid therapy, add about 1.6 mEq/L to the serum Na⁺ for every 100 mg/dL of glucose that is above 100 mg/dL.

Complete blood picture (CBC): A Complete Blood Count (CBC) is done as part of the initial tests to look for infection and see haematological status overall, which can affect management in DKA patients. A CBC can show leukocytosis (too many white blood cells) or anaemia (not having enough red blood cells), which could mean an infection or a stress response. This helps doctors figure out accompanying complications during DKA episodes.

Urinalysis: During the first lab test for diabetic ketoacidosis, serum and/or urine ketones (through blood ketone measurement, if available, or dipstick urinalysis) are used to confirm ketosis. Glucose, electrolytes, and acid-base status are also checked during diagnosis and monitoring. Urinalysis in DKA mainly finds glucosuria (presence of glucose in urine) and ketonuria (presence of ketone bodies in urine), but it isn't as good as direct serum β-hydroxybutyrate measurements, which show the severity of ketoacidosis and treatment response in patients.

Additional tests

These are used in cases of suspected diabetic ketoacidosis; further tests are advised to evaluate the extent of metabolic disturbance and to determine any underlying precipitating factors. Health care physicians may perform the following tests: 

• Electrocardiogram (ECG)
• Chest X-ray
• Glycosylated haemoglobin (HBA1C)
• Serum lactate
• Cultures(blood/urine/sputum)
  
  

Electrocardiogram (ECG): It is suggested as an additional test to detect heart problems and electrolyte changes (such as those caused by potassium imbalance) that can occur in DKA and help identify the underlying causes, such as myocardial ischemia (impaired blood flow to the heart muscle). ECG is not used to diagnose DKA itself. Instead, it is used with labs and other tests to help manage the condition by showing how metabolic disturbances affect the heart during the emergency evaluation.

Chest X-ray: A chest X-ray is not a standard test for diagnosing diabetic ketoacidosis (DKA), but it is done to rule out pneumonia or other lung-related causes when respiratory symptoms or infection are suspected. This is done as part of evaluating precipitating factors and complications.

Glycosylated haemoglobin (HBA1C): When diagnosing diabetic ketoacidosis (DKA), HbA1c is an additional test that can help determine whether the crisis is caused by long-term poor glycemic control or by new-onset diabetes, alongside other important tests, including blood glucose, ketones, acid-base status, electrolytes, and possible causes (like infection).

Serum lactate: In cases of diabetic ketoacidosis (DKA), it is important to check serum lactate levels in any patient with hyperglycemia and metabolic acidosis to evaluate lactic acidosis or other acid-base imbalance in addition to ketones. High serum lactate levels can cause the high anion gap seen in DKA and may indicate hypoperfusion or sepsis. This is an important additional test to differentiate and assess severity.

Cultures (blood/urine/sputum): In diabetic ketoacidosis, clinicians perform blood and urine cultures in suspected patients to identify infection as a precipitating factor and to identify underlying sepsis triggers; sputum culture is performed if respiratory infection is suspected.

Diagnostic criteria for severity

The severity of a condition is based on the frequency, intensity of symptoms, and impact on quality of life. Diabetic ketoacidosis classification is standardized into the following categories, which include:

• Mild DKA
• Moderate DKA
• Severe DKA
  
  

Mild DKA: It is characterised by an arterial pH between 7.25 and 7.30 and serum bicarbonate levels ranging from 15 to 18 mmol/L, accompanied by positive ketones, while the patient maintains alertness (normal mental status), signifying mild metabolic acidosis severity.

Moderate DKA: It is characterized by arterial/venous pH levels ranging from 7.0 to 7.25 or serum bicarbonate concentrations between 10 and 15 mmol/L, accompanied by ketonemia (elevated level of ketone bodies) and hyperglycemia (high serum glucose), with patients presenting either alert or drowsy.

Severe DKA: The most serious type of DKA is severe diabetic ketoacidosis, which is characterized by an arterial/venous pH of less than 7.0 and a serum bicarbonate level of less than 10 mmol/L, along with a change in mental status, such as stupor (state of near-unconsciousness) or coma. It shows severe metabolic acidosis with high ketone levels, and because of the high risk of death and illness, it usually needs to be managed in an intensive care unit.

✅Diabetic Ketoacidosis Differential Diagnosis

✅Diabetic Ketoacidosis Treatment Goals

Need clarity on DKA diagnosis or treatment options?

Get a free second opinion from the best Endocrinologists

At PACE Hospitals, we are committed to providing our patients with the best possible care, and that includes offering second medical opinions with super specialists for treatment or surgery. We recommend everyone to get an expert advance medical second opinion, before taking decision for your treatment or surgery.

DKA is a life-threatening medical emergency that needs to be treated in a hospital, preferably in an ICU or high-dependency unit. The main goals of diabetic ketoacidosis management are to restore volume of blood flow, correct electrolyte imbalances, prevent ketosis, and normalize blood sugar.

The following flow chart and steps are based on standardized diabetic ketoacidosis treatment algorithm for adults, focusing on the first 24 hours of care, which include:

Initial Steps (Phase I: 0-6 hours)

• Collection of a blood sample before starting IV fluids
• Fluid replacement (essential step 1)
• Potassium correction (essential step 2)
• Insulin therapy (essential step 3)
  
  

Collection of blood sample before starting IV fluids: Before starting intravenous fluids to help doctors make safe treatment decisions, the first steps in managing DKA are to draw blood for a full metabolic profile (electrolytes, glucose, ketones, acid–base status). This ensures that dehydration and electrolyte levels are accurately measured, so fluids and insulin can be given in the right amounts.

Fluid replacement (essential step 1): The first step in treating diabetic ketoacidosis is to quickly replace fluids with an IV infusion of isotonic saline (0.9% sodium chloride, e.g., 1-1.5 L first hour) and switch to 0.45% saline if corrected high sodium levels. This will bring the circulating volume back to normal and improve kidney perfusion. Early fluid therapy alone can significantly lower blood sugar levels and correct dehydration before insulin therapy begins to work.

Potassium correction (essential step 2): According to DKA guidelines, if serum potassium is less than 3.3 mmol/L, potassium must be corrected before starting IV insulin. Suppose it is between 3.3 and 5.3 mmol/L, potassium supplementation at 20–30 mEq potassium per litre of IV fluids. should be given concurrently with insulin. If it is above 5.3 mmol/L, supplementation is not needed initially, but levels must be monitored.

Insulin therapy (essential step 3): Once IV fluid resuscitation has begun and potassium levels are >3.3 mEq/L, then diabetic ketoacidosis medication with continuous intravenous regular insulin should be started at a rate of 0.05–0.1 U/kg/h to reduce blood glucose levels and inhibit lipolysis (breakdown of fat) and ketogenesis (formation of ketone bodies). Insulin infusion continues until DKA resolves, indicated by blood glucose below 200 mg/dL and normalized pH and bicarbonate levels.

Ongoing Management (Phase II: 6-12 hours)

• Glucose monitoring 
• Fluid type switch 
• Potassium management 
  
  

Glucose monitoring: Blood glucose levels must be monitored every hour during ongoing management until DKA is resolved. Venous pH, electrolytes, and ketones should be assessed every 2 to 4 hours to guide therapeutic adjustments. It also says that if blood sugar is high (≥250 mg/dL) during illness, it is necessary to monitor glucose levels every 4–6 hours and test for ketones to prevent DKA from worsening.

Fluid type switch: After the first resuscitation with isotonic saline to restore circulating volume, intravenous fluids are changed to 0.45% saline (half-normal saline) if the serum sodium level is normal or elevated. This is part of ongoing DKA management. When the blood sugar level drops to about 250 mg/dL during treatment, the IV fluid regimen is changed to include 5% dextrose (e.g., adding dextrose to the maintenance fluid) to prevent hypoglycemia (low blood sugar) while insulin therapy continues.

Potassium management: When treating diabetic ketoacidosis (DKA), the levels of potassium in the blood are used to decide potassium replacement. If K⁺ is less than 3.3 mmol/L, potassium replacement should be aggressive, and insulin should be given later when K⁺ is between 3.3 and 3.5 mmol/L, to prevent arrhythmias, which can be life-threatening. If K+ is between 3.3 and 5.3 mmol/L, potassium is added to IV fluids. If K+ is above 5.3 mmol/L, replacement is reduced or stopped with close monitoring. These steps make sure that serum potassium stays in a safe range while DKA is being treated. This is because the body's total potassium level is depleted, even if the first readings are normal or high. If not managed, insulin therapy can push potassium into cells, which can cause hypokalemia.

Resolution and transition (Phase III: 12-24 hours)

• Resolution criteria
• Precipitant management
• Specialist consultation

Resolution criteria: Diabetic ketoacidosis management should monitor closely for glucose and metabolic acidosis until resolution of diabetic ketoacidosis (normalisation of metabolic parameters). Upon resolution and the patient's ability to take oral medications, switching to subcutaneous insulin (S.C) should be started, while continuing intravenous insulin until adequate subcutaneous coverage has been acquired to prevent rebound hyperglycemia and recurrent ketoacidosis.

Precipitant management: When managing DKA, subcutaneous long-acting and short-acting insulin should be given before stopping the IV insulin infusion to avoid rebound hyperglycemia and ketosis. This should happen after biochemical and clinical improvement. To prevent DKA from rebounding and to help it resolve, the underlying diabetic ketoacidosis mechanism that triggers infection or insulin nonadherence must be identified and treated simultaneously.

Specialist consultation: When metabolic parameters like blood glucose, pH, bicarbonate, and anion gap go back to normal, DKA is resolved. To avoid rebound hyperglycemia, it is recommended to start switching to subcutaneous insulin by giving basal insulin 2 to 4 hours before stopping IV insulin. Having a specialist diabetes team, such as a consultant or endocrinologist, involved makes DKA management safer, helps with monitoring resolution, discharge planning, and patient education.

Non-pharmacological treatment

Non-pharmacological management of diabetic ketoacidosis (DKA) emphasizes immediate fluid resuscitation, correction of electrolyte imbalances, and careful monitoring of vital signs as an adjunct to insulin therapy, to restore metabolic stability.

• Fluid resuscitation
• Monitoring and surveillance
• Nutritional management
• Patient education
• Supportive care
  
  

Fluid resuscitation: Immediate fluid resuscitation corrects hypovolemia (reduces blood volume by 10–15% of body weight), restores tissue perfusion, and gets rid of ketones in patients with 

DKA. Hydration enhances glycemic control independently of insulin by improving renal function and decreasing counter-regulatory hormones.

Monitoring and surveillance: It is very important to monitor vital signs, fluid levels, electrolytes, and metabolic parameters all the time when managing DKA to avoid problems like cerebral edema (brain swelling). In a critical care unit, frequent reassessment makes sure that therapy adjustments are made immediately based on the patient's clinical and lab response. 

Nutritional management: Basically, diet management is initiated once diabetic ketoacidosis is resolved, switching to the oral route with meals moderate in carbohydrates to prevent DKA recurrence. Oral nutrition is not initiated during the acute phase to maintain fluid and electrolyte balance.

Patient education: It includes identifying DKA triggers, such as illness or insulin omission (intentionally skipping/not taking adequate insulin doses as prescribed), and seeking immediate medical attention, with instructions and patient education. After DKA, ongoing lifestyle counselling stresses monitoring blood sugar levels and medication adherence to avoid future attacks.

Supportive Care: Supportive measures include identifying precipitating factors like infections, often combined with poor diabetes control, avoiding complications such as hypoglycemia, and providing care. Restoring circulation and kidney function with fluids helps the body heal without drugs.

Diabetic Ketoacidosis Prognosis

Early evaluation and treatment have significantly improved the outlook for diabetic ketoacidosis (DKA), but it is still a serious and possibly life-threatening emergency. Timely management of fluids, insulin, and electrolyte correction “greatly improves patient outcomes,” reducing morbidity and mortality when treated promptly. In general, the overall prognosis is good in places where treatment is easily accessible, but delayed diagnosis or poor management can still cause serious problems or death, especially in vulnerable populations (groups that are already weak).

Diabetic Ketoacidosis (DKA) Treatment Cost in Hyderabad, India

The cost of Diabetic Ketoacidosis (DKA) treatment in Hyderabad generally ranges from ₹80,000 to ₹6,00,000 and above (approx. US $960 – US $7,230).

The exact cost of DKA treatment varies depending on the severity of acidosis, blood sugar levels, presence of dehydration, electrolyte imbalance, underlying infection, need for ICU admission, and duration of hospital stay. Additional factors such as insulin infusion therapy, continuous monitoring, laboratory investigations, and management of complications (shock, kidney injury, or cerebral edema) may influence the total cost — along with hospital infrastructure, ICU facilities, and availability of cashless treatment options, TPA corporate tie-ups, and insurance assistance wherever applicable.

Cost Breakdown According to Type of DKA Treatment

• Mild to Moderate DKA With Medical Management – ₹80,000 – ₹1,80,000 (US $960 – US $2,165)
• DKA Requiring ICU Monitoring & Insulin Infusion – ₹1,20,000 – ₹3,00,000 (US $1,445 – US $3,615)
• Severe DKA With Electrolyte Correction & Intensive Monitoring – ₹2,00,000 – ₹4,50,000 (US $2,410 – US $5,420)
• DKA With Complications (Shock / Kidney Injury) – ₹3,00,000 – ₹6,00,000 (US $3,615 – US $7,230)
• Prolonged ICU Care with Multi-System Support – ₹4,00,000 – ₹6,00,000+ (US $4,820 – US $7,230+)

Frequently Asked Questions (FAQs) on Diabetic Ketoacidosis (DKA)

What are the signs and tests used to evaluate diabetic ketoacidosis (DKA)?

Blood tests are used to diagnose diabetic ketoacidosis (DKA), which is a life-threatening emergency that is often caused by an infection or missing an insulin dose. Doctors check for high blood sugar (usually over 250 mg/dL but can be lower), ketones in the blood or urine, and acidic blood (pH less than 7.3 or low bicarbonate <18 mEq/L). Symptoms include vomiting, fruity breath, dehydration, and mental confusion.

Why is potassium given in diabetic ketoacidosis?

Potassium goes back into the cells when we give insulin and fluids to correct DKA. This can suddenly lower the potassium levels in the blood, which raises the risk of heart problems or muscle problems. To maintain normal blood levels of potassium and prevent these complications, it is recommended to add potassium to the IV fluids..

What test confirms diabetic ketoacidosis?

Which laboratory finding indicates diabetic ketoacidosis?

Laboratory tests indicate that diabetic ketoacidosis is present when there is severe hyperglycemia (blood glucose levels of 250–300 mg/dL or higher), metabolic acidosis (arterial pH levels of less than 7.30 and low serum bicarbonate levels of less than 15–18 mEq/L), and high levels of ketones in the blood or urine because of insulin deficiency.

How long does someone need to stay in the hospital for DKA?

According to studies of hospital data, the average length of stay (LOS) is between 3.2 and 3.4 days. If treated promptly, DKA recovery (removal of acidosis) usually occurs within 24 hours, but it can take longer depending on the severity. Some data show that most people with DKA are treated within 24 to 72 hours, depending on the severity and whether complications exist. In some cases, patients may stay longer if they have underlying conditions (like infection or severe illness) that caused the DKA. Patients are discharged when the DKA has resolved (blood pH is normal), they can eat and drink normally, and they have been switched to subcutaneous insulin.

Can patients be unconscious from DKA?

Yes, diabetic ketoacidosis can cause individuals to become unconscious if untreated. Advanced DKA is a life-threatening emergency that can lead to coma, which is a state of being unconscious for a long time.

Is DKA always managed in the intensive care unit (ICU)?

No, not all DKA patients should be treated in an ICU. Instead, they should be hospitalized and closely monitored. ICU care is only for patients who need intensive monitoring or life support, such as those with shock, severe acidosis or altered mental status. Many people with DKA, especially those with mild to moderate cases, can be treated outside of the ICU. Only those with complications that need critical care are admitted to the ICU.

What do ketone levels mean in diabetic ketoacidosis?

When the body breaks down fat rather than glucose for energy, it produces ketone bodies, which are confirmed by blood tests. Normal results under 0.6 mmol/L indicate the absence of ketone bodies in the blood. If results are high (e.g., >3.0 mmol/L) or positive, it means ketones are present; if present in a very high range and patients experience symptoms, it could mean dangerous ketoacidosis (like diabetic ketoacidosis), which is a medical emergency that needs immediate treatment.

Can DKA occur with normal blood sugar?

Yes, diabetic ketoacidosis (DKA) can happen even when blood sugar is normal or only mildly raised, which is called euglycemic DKA (EDKA), and it happens when glucose levels are below 250 mg/dL. It is dangerous because patients still have metabolic acidosis and ketosis features, and normal glucose levels can delay diagnosis and treatment when clinicians rely only on glucose levels. It is often caused by SGLT2 inhibitors (oral diabetic medications), pregnancy, or starvation.

What are the three diagnostic criteria for DKA?

To diagnose diabetic ketoacidosis (DKA), three characteristics must be present at the same time: hyperglycemia, which reflects blood sugar levels are usually higher than 250 mg/dL; ketosis, which indicates ketones are present in the blood or urine; and (3) metabolic acidosis, which means the arterial/venous pH < 7.3 and the serum bicarbonate is <15–18 mEq/L.

At what blood sugar level does a diabetic coma occur?

If blood sugar levels are very high, like in hyperosmolar hyperglycemic state (where levels are usually above ~600 mg/dL or 33.3 mmol/L), or very low, such as in severe hypoglycemia (where levels drop below ~70 mg/dL or 3.9 mmol/L), especially below ~54 mg/dL, with risk of loss of consciousness and coma if untreated.

How is diabetic ketoacidosis prevented?

Prevention of diabetic ketoacidosis involves regular insulin injections, frequent blood glucose testing, and effective management of sick days. It involves measuring blood glucose three to four times a day (more frequently when sick), measuring ketones when blood glucose rises above 250mg/dL, and staying well-hydrated.

Can stress cause diabetic ketoacidosis?

Yes, DKA may be precipitated by stress factors. The release of stress hormones increases glucose concentration and inhibits insulin, leading to the breakdown of fats to obtain energy and increased ketone production.

How does dehydration contribute to diabetic ketoacidosis?

What complications can arise from untreated diabetic ketoacidosis?

If left untreated, DKA will be a medical emergency and may cause many serious complications such as coma, organ failure, brain swelling (cerebral edema), and even death. Other critical problems caused by the condition include severe dehydration, hypokalemia (low potassium levels), and hypoglycemia (low blood sugar) from treatment.

Is DKA more common in children or adults?

Diabetic ketoacidosis (DKA) can occur at any age but is most common in adolescents and young adults rather than exclusively in children. While DKA does occur in people under 18, it is not more than twice as frequent in this age group compared with adults.

Can DKA recur?

Yes, DKA can occur more than once, which is very serious and avoidable when 20 percent of people with diabetes, typically adolescents, account for 80 percent of DKA patients because of high HBA1C levels. DKA is frequently seen due to either an omission in insulin treatment or psychological reasons, and a lack of access to care.

Is Diabetic Ketoacidosis Treatment Covered by Insurance at PACE Hospitals?